High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania

BACKGROUND: In 2006, the first-line anti-malarial drug treatment in Tanzania was changed from sulphadoxine-pyrimethamine (SP) to artemether-lumefantrine (ALu), an artemisinin-based combination (ACT), since when the use of SP has been restricted for intermittent preventive treatment in pregnancy (IPT...

Descripción completa

Detalles Bibliográficos
Autores principales: Matondo, Sungwa I, Temba, Godfrey S, Kavishe, Adelaida A, Kauki, Julius S, Kalinga, Akili, van Zwetselaar, Marco, Reyburn, Hugh, Kavishe, Reginald A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998221/
https://www.ncbi.nlm.nih.gov/pubmed/24751352
http://dx.doi.org/10.1186/1475-2875-13-152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998221/
https://www.ncbi.nlm.nih.gov/pubmed/24751352
http://dx.doi.org/10.1186/1475-2875-13-152

Ejemplares similares